Zuberitamab (Anti-CD20)

Zuberitamab (Anti-CD20) is a human monoclonal antibody that targets CD20, with the potential to be used in research on diffuse large B-cell lymphoma. MW : 145.48 KD.
Supplier Selleck Chemicals
Product # A2809
Sku # A2809-1mg*5
Pricing 1mg*5, $1690.00
Feedback